BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9023621)

  • 1. Titrated intravenous opioids from the same syringe: an infection risk?
    Taylor M; Bourke J; Anderson M; Davey R; Kelly AM; Guthrie B
    J Accid Emerg Med; 1997 Jan; 14(1):33-5. PubMed ID: 9023621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbial contamination of syringes during preparation: the direct influence of environmental cleanliness and risk manipulations on end-product quality.
    Stucki C; Sautter AM; Favet J; Bonnabry P
    Am J Health Syst Pharm; 2009 Nov; 66(22):2032-6. PubMed ID: 19890087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unexpected high risk of contamination with staphylococci species attributable to standard preparation of syringes for continuous intravenous drug administration in a simulation model in intensive care units.
    van Grafhorst JP; Foudraine NA; Nooteboom F; Crombach WH; Oldenhof NJ; van Doorne H
    Crit Care Med; 2002 Apr; 30(4):833-6. PubMed ID: 11940754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating the impact of clinical anaesthetic practice on bacterial contamination of intravenous fluids and drugs.
    Mahida N; Levi K; Kearns A; Snape S; Moppett I
    J Hosp Infect; 2015 May; 90(1):70-4. PubMed ID: 25648939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of microbial contamination associated with different preparation methods for neonatal intravenous fat emulsion infusion.
    Crill CM; Hak EB; Robinson LA; Helms RA
    Am J Health Syst Pharm; 2010 Jun; 67(11):914-8. PubMed ID: 20484215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a closed-system cytotoxic transfer device in a pharmaceutical isolator.
    Vyas N; Turner A; Clark JM; Sewell GJ
    J Oncol Pharm Pract; 2016 Feb; 22(1):10-9. PubMed ID: 25073678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple withdrawals from single-use vials: a study on sterility.
    Ripoll Gallardo A; Meneghetti G; Ragazzoni L; Kroumova V; Ferrante D; Ingrassia PL; Ruzza P; Dell'Era A; Boniolo E; Koraqe G; Faggiano F; Della Corte F
    Int J Pharm; 2015 May; 485(1-2):160-3. PubMed ID: 25769293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbiologic contamination of automatic injectors at MDCT: experimental and clinical investigations.
    Buerke B; Mellmann A; Stehling C; Wessling J; Heindel W; Juergens KU
    AJR Am J Roentgenol; 2008 Dec; 191(6):W283-7. PubMed ID: 19020216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using medium-fill simulation to establish a benchmark microbiological contamination rate for low-risk-level compounding.
    Trissel LA; Ogundele AB; Ingram DS; Saenz CA; Gentempo JA
    Am J Health Syst Pharm; 2003 Sep; 60(18):1853-5. PubMed ID: 14521036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syringe plunger contamination by hazardous drugs: a comparative study.
    Smith ST; Szlaczky MC
    J Oncol Pharm Pract; 2014 Oct; 20(5):381-5. PubMed ID: 24598373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbial stability of syringes of anesthetic drugs prepared in the operating room.
    Segal S; Gunawan A; McLaughlin DH; Palavecino E
    J Clin Anesth; 2019 Aug; 55():20-23. PubMed ID: 30586662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of two sterility testing methods for intravenous admixtures.
    Condella F; Eichelberger K; Foote LC; Griffin RE
    Hosp Pharm; 1980 Jun; 15(6):305-10. PubMed ID: 10247270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Aseptic non-touch technique in the operating room: keep it simple].
    Pans SJ; Molmans E; Marczinski SC; Bijker JB; Snijdelaar DG
    Ned Tijdschr Geneeskd; 2015; 159():A9471. PubMed ID: 26577383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved aseptic technique can reduce variable contamination rates of ward-prepared parenteral doses.
    Austin P; Elia M
    J Hosp Infect; 2013 Feb; 83(2):160-3. PubMed ID: 23313030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modified syringe design prevents plunger-related contamination--results of contamination and flow-rate tests.
    Olivier LC; Kendoff D; Wolfhard U; Nast-Kolb D; Nazif Yazici M; Esche H
    J Hosp Infect; 2003 Feb; 53(2):140-3. PubMed ID: 12586575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbial contamination of antiseptics and disinfectants.
    Danchaivijitr S; Dhiraputra C; Rongrungruang Y; Srihapol N; Pumsuwan V
    J Med Assoc Thai; 2005 Dec; 88 Suppl 10():S133-9. PubMed ID: 16850658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Environmental contamination, product contamination and workers exposure using a robotic system for antineoplastic drug preparation.
    Sessink PJ; Leclercq GM; Wouters DM; Halbardier L; Hammad C; Kassoul N
    J Oncol Pharm Pract; 2015 Apr; 21(2):118-27. PubMed ID: 24567041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The incidence of blood contamination of lead unit dose containers with and without single-use protective inserts used with commercially prepared radiopharmaceutical unit doses.
    Pickett MW; Kosegi JE; Thomas KS; Waterstram-Rich KM
    J Nucl Med Technol; 1998 Sep; 26(3):200-3. PubMed ID: 9755441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial contamination of propofol in the operating theatre.
    Soong WA
    Anaesth Intensive Care; 1999 Oct; 27(5):493-6. PubMed ID: 10520390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A microbiological study of the contamination of the syringes used in anaesthesia practice.
    Lessard MR; Trépanier CA; Gourdeau M; Denault PH
    Can J Anaesth; 1988 Nov; 35(6):567-9. PubMed ID: 3203452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.